Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Optineurin ELISA Kit (AC2929)
Cat.#: ASET-1518
Specifications
Description Human Optineurin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Optineurin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.024 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.25-20 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1947 Human Wnt3a ELISA Kit (AC3358) Quantitative inquiry ASET-1406 Human Ferritin Light Chain ELISA Kit (AC2817) Quantitative inquiry ASET-1350 Human Clathrin Light Chain ELISA Kit (AC2761) Quantitative inquiry ASET-1537 Rat EAAT3 ELISA Kit (AC2948) Quantitative inquiry ASET-2259 Human NRSN2 ELISA Kit (AC3670) Quantitative inquiry ASET-1683 Human NOX3 ELISA Kit (AC3094) Quantitative inquiry ASET-2246 Human NT-4 ELISA Kit (AC3657) Quantitative inquiry ASET-1502 Mouse Apelin ELISA Kit (AC2913) Quantitative inquiry ASET-1778 Human SLIT3 ELISA Kit (AC3189) Quantitative inquiry ASET-1122 Rat CX3CR1 ELISA Kit (AC2533) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket